Literature DB >> 866565

Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis.

P Lee, M B Urowitz, A A Bookman, B E Koehler, H A Smythe, D A Gordon, M A Ogryzlo.   

Abstract

Observations made on 110 patients with SLE over a four and a half year period have been reviewed. The patients were seen at intervals of two months when, both clinical and serological findings were recorded, according to a set protocol. The results have been presented with particular reference to nephritis, neurological manifestations, infections, aseptic necrosis, mortality and predicted survival. Such studies have led to the identification of various prognosis factors in SLE, and assisted in providing better directed therapy. The results indicate a milder from of SLE in the patients of this series when compared with previously published studies, and is more representative of the wide spectrum of disease severity seen in the general population.

Entities:  

Mesh:

Year:  1977        PMID: 866565

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  45 in total

Review 1.  Neuropsychiatric lupus.

Authors:  J G Hanly
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 2.  Epidemiology of systemic lupus erythematosus.

Authors:  N Hopkinson
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 3.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

4.  EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.

Authors:  C-S Yee; C Gordon; C Dostal; P Petera; J Dadoniene; B Griffiths; B Rozman; D A Isenberg; G Sturfelt; O Nived; J H Turney; A Venalis; D Adu; J S Smolen; P Emery
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  Rheumatic disease in Jamaica.

Authors:  W A Wilson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

6.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

7.  Systemic lupus erythematosus in childhood.

Authors:  F Caeiro; F M Michielson; R Bernstein; G R Hughes; B M Ansell
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

8.  Tuberculous choroidal granulomas in a patient with systemic lupus erythematosus. A case report.

Authors:  J C Wang; G C Chuah; E Y Yap
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

9.  The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms.

Authors:  B Bresnihan; R Hohmeister; J Cutting; R L Travers; M Waldburger; C Black; T Jones; G R Hughes
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

10.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.